Back to Results

Michael D. House, MD Accepting New Patients Virtual Appointments Available

Programs + Specialties
Training + Education University of Southern California; Tufts Medical Center; Los Angeles County, University of Southern California Women and Children's Hospital
Board Certifications Maternal-Fetal Medicine, Obstetrics and Gynecology
NPI # 1851405740
Gender Male
Accepted Insurances View Accepted Insurances at Tufts MC + Tufts Children's Hospital

Tufts Medical Center
South Building, 2nd Floor
800 Washington St.
Box 360
Boston, MA 02111
Phone #: 617-636-4549
Fax #: 617-636-4202

2020, Appointed to the Board of the Perinatal Quality Foundation (ex-officio)
2016-2020, "Top Doctor," Boston Magazine
2013, Elected President of New England Perinatal Research Society
2012, Elected Vice-President of New England Perinatal Research Society
2012, Award for Best Poster at 32nd Annual Meeting, SMFM
2008, Elected member, Perinatal Research Society
2007, Reproductive Scientist Development Program, K12 Award, NICHD
2006, Best Oral Presentation at SMFM
2005, Best Oral Presentation at SMFM
2002, AAAOGF - SMFM Scholarship Award

Koullali B, Zhang Y, Peterson A, Raia N, Kaplan DL, House MD. Cervical Augmentation with an Injectable Silk-Based Gel: Biocompatibility in a Rat Model of Pregnancy. Reprod Sci. 2020 May;27(5):1215-1221. doi: 10.1007/s43032-019-00111-7. Epub 2020 Jan 6. PubMed PMID:32046447; NIHMSID:NIHMS1548296.

Zhang Y, Raia N, Peterson A, Kaplan DL, House M. Injectable Silk-Based Hydrogel as an Alternative to Cervical Cerclage: A Rabbit Study. Tissue Eng Part A. 2020 Apr;26(7-8):379-386. doi: 10.1089/ten.TEA.2019.0210. Epub 2019 Nov 14. PubMed PMID:31621512; PubMed Central PMCID:PMC7187963.

Koullali B, House MD. Scaffolds for cervical tissue engineering. In: Mozafari M, Sefat F, Atala A editos. Handbook of Tissue Engineering Scaffolds: Volume Two, 1st ed. Elsevier; 2019. p 333-342.

Raia NR, Bakaysa SL, Ghezzi CE, House MD, Kaplan DL. Ex vivo pregnant-like tissue model to assess injectable hydrogel for preterm birth prevention. J Biomed Mater Res B Appl Biomater. 2020 Feb;108(2):468-474. doi: 10.1002/jbm.b.34403. Epub 2019 May 9. PubMed PMID:31070848.

House M, Kelly J, Klebanov N, Yoshida K, Myers K, Kaplan DL. Mechanical and Biochemical Effects of Progesterone on Engineered Cervical Tissue. Tissue Eng Part A. 2018 Dec;24(23-24):1765-1774. doi: 10.1089/ten.TEA.2018.0036. Epub 2018 Jul 23. PubMed PMID:29855229; PubMed Central PMCID:PMC6302671.

Westervelt AR, Fernandez M, House M, Vink J, Nhan-Chang CL, Wapner R, Myers KM. A parameterized ultrasound-based finite element analysis of the mechanical environment of pregnancy. J Biomech Eng 2017;139.doi:10.1115/1.4036259.

Smith-Dupont KB,Wagner CE, Witten J, Conroy K, Rudoltz, Pagidas, Snegovskikh V,7, House M, Ribbeck K. Probing the potential of mucus permeability to signify preterm birth risk. Sci Rep 2017;7:10302.doi: 10.1038/s41598-017-08057-z.

Myers KM, Feltovich H, Mazza E, Vink J, Bajka M, Wapner RJ, Hall TJ, House M. The mechanical role of the cervix in pregnancy. J Biomech. 2015 Jun 25;48(9):1511-23. doi: 10.1016/j.jbiomech.2015.02.065. Epub 2015 Mar 11. PubMed PMID: 25841293; PubMed Central PMCID: PMC4459908.

Feltovich H, House M. Innovative methods of cervical assessment and potential for novel treatment. Clin Obstet Gynecol. 2014 Sep;57(3):531-6. doi: 10.1097/GRF.0000000000000049. Review. PubMed PMID: 25084285; PubMed Central PMCID: PMC4120240.

Critchfield AS, Mccabe R, Klebanov N, Richey L, Socrate S, Norwitz ER, Kaplan DL, House M. Biocompatibility of a sonicated silk gel for cervical injection during pregnancy: in vivo and in vitro study. Reprod Sci. 2014 Oct;21(10):1266-73. doi: 10.1177/1933719114522551. Epub 2014 Feb 11. PubMed PMID: 24520079.

House M, Tadesse-Telila S, Norwitz ER, Socrate S, Kaplan DL. Inhibitory effect of progesterone on cervical tissue formation in a three-dimensional culture system with human cervical fibroblasts. Biol Reprod. 2014 Jan 30;90(1):18. doi: 10.1095/biolreprod.113.112540. Print 2014 Jan. PubMed PMID: 24285720; PubMed Central PMCID: PMC4076401.

Critchfield AS, Yao G, Jaishankar A, Friedlander RS, Lieleg O, Doyle PS, McKinley G, House M, Ribbeck K. Cervical mucus properties stratify risk for preterm birth. PLoS One. 2013 Aug 1;8(8):e69528. doi: 10.1371/journal.pone.0069528. Print 2013. PubMed PMID: 23936335; PubMed Central PMCID: PMC3731331.

Heard AJ, Socrate S, Burke KA, Norwitz ER, Kaplan DL, House MD. Silk-based injectable biomaterial as an alternative to cervical cerclage: an in vitro study. Reprod Sci. 2013 Aug;20(8):929-36. doi: 10.1177/1933719112468952. Epub 2012 Dec 27. PubMed PMID: 23271162; PubMed Central PMCID: PMC3713644.

7. House M, McCabe R, Socrate S. Using imaging-based, three-dimensional models of the cervix and uterus for studies of cervical changes during pregnancy. Clin Anat. 2013 Jan;26(1):97-104. doi: 10.1002/ca.22183. Epub 2012 Nov 21. Review. PubMed PMID: 23168534.

House M, Daniel J, Elstad K, Socrate S, Kaplan DL. Oxygen tension and formation of cervical-like tissue in two-dimensional and three-dimensional culture. Tissue Eng Part A. 2012 Mar;18(5-6):499-507. doi: 10.1089/ten.TEA.2011.0309. Epub 2011 Nov 1. PubMed PMID: 21919792; PubMed Central PMCID: PMC3286821.

Myers KM, Socrate S, Paskaleva A, House M. A study of the anisotropy and tension/compression behavior of human cervical tissue. J Biomech Eng. 2010 Feb;132(2):021003. doi: 10.1115/1.3197847. PubMed PMID: 20370240.

House M, Sanchez CC, Rice WL, Socrate S, Kaplan DL. Cervical tissue engineering using silk scaffolds and human cervical cells. Tissue Eng Part A. 2010 Jun;16(6):2101-12. doi: 10.1089/ten.TEA.2009.0457. PubMed PMID: 20121593; PubMed Central PMCID: PMC2949265.

Michael House is a maternal-fetal medicine physician at Tufts MC

Michael House, MD Receives Grand Prize for Novel Device to Prevent Preterm Birth

Learn more about the device
Graphic that says In the News

Tomo Tarui, MD and Michael House, MD will be collaborating in a study

Learn about the study
Top Doctors Boston Magazine 2020

2020 “Top Doctors” at Tufts MC and Tufts Children's Hospital

See our Top Doctors
Michael House, MD of Mother Infant Research Institute at Tufts Medical Center in Boston.

Dr. Michael House quoted on NPR’s Morning Edition

Read the full interview
Group of all MIRI researchers

MIRI researchers on the road

Learn about the MIRI researchers on the road
Lindsey and Summer

Lindsey's story: Summer couldn't come soon enough

Read Lindsey's story
Michael House, MD of Mother Infant Research Institute at Tufts Medical Center in Boston.

MIRI Researcher Dr. Michael House receives four-year NIH research grant.

MIRI Researcher Dr. Michael House receives four-year NIH research grant. - Read More
Boston Magazine 'Top Doctor' Award 2016

Boston magazine honors 2016 “Top Doctors” at Tufts Medical Center and Tufts Children's Hospital.

2016 Boston magazine Top Doctors
Michael House, MD of Mother Infant Research Institute at Tufts Medical Center in Boston.

Dr. Michael House a COVID-19 Seed Fund Awardee

Dr. Michael House a COVID-19 Seed Fund Awardee - Read More
Michael House, MD of Mother Infant Research Institute at Tufts Medical Center in Boston.

Dr. Michael House receives SMFM/ABOG Bridge Grant

Read about the grant
Michael House, MD of Mother Infant Research Institute at Tufts Medical Center in Boston.

Dr. Michael House receives STTR grant

Read about the grant
Boston Magazine 'Top Doctor' Award 2017

Boston Magazine honors 2017 “Top Doctors” at Tufts Medical Center and Tufts Children's Hospital.

2017 Boston Magazine Top Doctors
Dr. Clarissa Yang on the cover of 2019 Boston Magazine Top Doctor issue.

2019 “Top Doctors” at Tufts MC and Tufts Children's Hospital

See our Top Doctors

NICHD R41HD102268
Small Business Technology Transfer (STTR) Program
A Novel Device for Cervical Insufficiency in Pregnant Women This STTR will develop an innovative medical device to treat cervical insufficiency with improved efficacy and fewer complications compared with traditional cerclage.
Role: PI

M2D2 Grand Prize Award
Massachusetts Life Sciences Center
Massachusetts Medical Device Development Center
The goal is to assist Cx Therapeutics in Developing an Innovative Medical Device to Treat Cervical Insufficiency Compared with Traditional Cerclage.

COVID-19 Rapid Response Seed Funding Grant
Reducing the stress associated with performing non-stress tests – evaluating potential acceptance for home-based monitoring. The study aims to gather information that can inform how to approach home-based non-stress tests; the likelihood that a test would result in a patient needing clinical care acutely via a retrospective chart review and the perspective of patients who would potentially undergo home-based testing with a prospective survey.
Role: PI

SMFM/ABOG Bridge Grant
Novel tools for studying cervical function and dysfunction during pregnancy.
The goal of the project is to gain critical insights into mechanisms of preterm birth where cervical dysfunction is the cause.
Role: Principal Investigator

NIH 1R01HD084695-01A1
“Mechanisms of Infection-Mediated Cervical Ripening.”
The goal of this project is to acquire a greater mechanistic understanding of biochemical pathways leading to cervical ripening, with a particular emphasis on infection-mediated cervical ripening.
Role: Co-Principal Investigator

MIT: Burroughs Wellcome Fund
Sub Award #5710003419 2013-2017
Properties and Functions of Cervical Mucus Associated with Preterm Birth
The goal is to increase understanding of the basic biological mechanisms underlying parturition and spontaneous birth using multidisciplinary approaches.
Role: TMC Principal Investigator

NICHD Scholar of the RSDP
K12HD000849 2007-2013
Cervical Tissue Engineering for Studying Obstetrical Biomechanics.
The goal is to use a tissue engineering strategy to study mechanisms of cervical remodeling during pregnancy.
Role: Principal Investigator

Burroughs Wellcome Fund – Preterm Birth Initiative
Beyond Cervical Length: Development of a Patient-Specific Model of Cervical Mechanical Function during Pregnancy.
The goal of this study was to determine biomechanical function of the cervix during pregnancy by combining three-dimensional ultrasound with biomechanical models of cervical mechanics.
Role: Principal Investigator

Dr. House's research focus is on studying the role of the cervix in normal and high-risk pregnancy. Normal cervical function is critical for a healthy pregnancy but premature cervical shortening and dilation is associated with preterm birth, which affects 12% of pregnancies in the United States. Research activities include 1) design and evaluation of three-dimensional models of cervical tissue to study remodeling of the cervical extracellular matrix, 2) investigation of the cervical biomechanical function using mechanical modeling techniques, 3) study of the barrier properties of cervical mucus as it relates to protection against intrauterine infection and 4) development of novel therapies such as injectable biomaterials to augment cervical function during pregnancy. This research is valuable for understanding why the cervix stays closed in normal pregnancy but shortens and opens in preterm birth. Successful accomplishment of this research relies on a collaborative multidisciplinary research team involving investigators with expertise in mechanical engineering, biology and maternal fetal medicine.